Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 225

1.

Exposure to metal oxide nanoparticles in physiological fluid induced synergistic biological effects in a keratinocyte model.

Cathe DS, Whitaker JN, Breitner EK, Comfort KK.

Toxicol Lett. 2017 Feb 15;268:1-7. doi: 10.1016/j.toxlet.2017.01.003. Epub 2017 Jan 16.

PMID:
28093221
2.

Comparative Long-Term Evaluation of Patients With Juvenile Inflammatory Myopathies.

Elahi HA, Bertorini TE, Igarashi M, Mays WH 3rd, Whitaker JN.

J Clin Neuromuscul Dis. 2016 Sep;18(1):21-7. doi: 10.1097/CND.0000000000000131.

PMID:
27552385
3.

The requirement of ammonium or other cations linked with p-cresol sulfate for cross-reactivity with a peptide of myelin basic protein.

Jackson PL, Cao L, Blalock JE, Whitaker JN.

Arch Biochem Biophys. 2003 Oct 15;418(2):119-24.

PMID:
14522583
4.

Immunohistochemical localization of citrullinated proteins in adult rat brain.

Nicholas AP, King JL, Sambandam T, Echols JD, Gupta KB, McInnis C, Whitaker JN.

J Comp Neurol. 2003 May 5;459(3):251-66.

PMID:
12655508
5.

Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.

Cohen JA, Cutter GR, Fischer JS, Goodman AD, Heidenreich FR, Kooijmans MF, Sandrock AW, Rudick RA, Simon JH, Simonian NA, Tsao EC, Whitaker JN; IMPACT Investigators.

Neurology. 2002 Sep 10;59(5):679-87.

PMID:
12221157
6.

Metabolic differences between multiple sclerosis subtypes measured by quantitative MR spectroscopy.

Pan JW, Coyle PK, Bashir K, Whitaker JN, Krupp LB, Hetherington HP.

Mult Scler. 2002 May;8(3):200-6.

PMID:
12120690
7.

Current immunotherapy for demyelinating diseases.

Bashir K, Whitaker JN.

Arch Neurol. 2002 May;59(5):726-31. Review. No abstract available.

PMID:
12020252
10.

Surgery for spinal cord compression in multiple sclerosis.

Bashir K, Hadley MN, Whitaker JN.

Curr Opin Neurol. 2001 Dec;14(6):765-9.

PMID:
11723386
11.

Medical and endovascular therapy for intracranial atherosclerotic vascular disease.

Whitaker JN.

Arch Neurol. 2001 Oct;58(10):1692-3. No abstract available.

PMID:
11594933
12.

Triptans for migraine headache: therapeutic progress meets a heterogeneous patient response.

Whitaker JN.

Arch Neurol. 2001 Sep;58(9):1482-3. Review. No abstract available.

PMID:
11559324
13.

Commentary on neutralizing antibodies to interferon beta in patients with multiple sclerosis.

Whitaker JN.

Arch Neurol. 2001 Aug;58(8):1301. No abstract available.

PMID:
11493175
14.

Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.

Cohen JA, Cutter GR, Fischer JS, Goodman AD, Heidenreich FR, Jak AJ, Kniker JE, Kooijmans MF, Lull JM, Sandrock AW, Simon JH, Simonian NA, Whitaker JN.

Arch Neurol. 2001 Jun;58(6):961-7.

PMID:
11405811
15.

Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice.

Sun D, Whitaker JN, Huang Z, Liu D, Coleclough C, Wekerle H, Raine CS.

J Immunol. 2001 Jun 15;166(12):7579-87.

16.

The potential for harm or benefit from inflammatory processes in stroke.

Whitaker JN.

Arch Neurol. 2001 Apr;58(4):674. No abstract available.

PMID:
11296004
17.

Relationship of urinary myelin basic protein-like material with cranial magnetic resonance imaging in advanced multiple sclerosis.

Whitaker JN, Wolinsky JS, Narayana PA, Bartolucci AA, Noseworthy JH, Lublin FD, Linde A, Gjörstrup P, Sullivan HC; North American Linomide Investigators.

Arch Neurol. 2001 Jan;58(1):49-54.

PMID:
11176936
18.

An IgM anti-MBP Ab in a case of Waldenstrom's macroglobulinemia with polyneuropathy expressing an idiotype reactive with an MBP epitope immunodominant in MS and EAE.

Noerager BD, Inuzuka T, Kira J, Blalock JE, Whitaker JN, Galin FS.

J Neuroimmunol. 2001 Feb 1;113(1):163-9.

PMID:
11137588
20.
21.

Surgery for cervical spinal cord compression in patients with multiple sclerosis.

Bashir K, Cai CY, Moore TA 2nd, Whitaker JN, Hadley MN.

Neurosurgery. 2000 Sep;47(3):637-42; discussion 642-3.

PMID:
10981751
22.

Enhanced T cell responsiveness to citrulline-containing myelin basic protein in multiple sclerosis patients.

Tranquill LR, Cao L, Ling NC, Kalbacher H, Martin RM, Whitaker JN.

Mult Scler. 2000 Aug;6(4):220-5.

PMID:
10962541
23.

Inhibition of experimental allergic encephalomyelitis in the Lewis rat by paclitaxel.

Cao L, Sun D, Cruz T, Moscarello MA, Ludwin SK, Whitaker JN.

J Neuroimmunol. 2000 Aug 1;108(1-2):103-11.

PMID:
10900343
24.
25.

Linomide in relapsing and secondary progressive MS: part II: MRI results. MRI Analysis Center of the University of Texas-Houston, Health Science Center, and the North American Linomide Investigators.

Wolinsky JS, Narayana PA, Noseworthy JH, Lublin FD, Whitaker JN, Linde A, Gjörstrup P, Sullivan HC.

Neurology. 2000 May 9;54(9):1734-41.

PMID:
10802777
26.

Linomide in relapsing and secondary progressive MS: part I: trial design and clinical results. North American Linomide Investigators.

Noseworthy JH, Wolinsky JS, Lublin FD, Whitaker JN, Linde A, Gjorstrup P, Sullivan HC.

Neurology. 2000 May 9;54(9):1726-33.

PMID:
10802775
27.

p-Cresol sulfate is the dominant component of urinary myelin basic protein like material.

Cao L, Kirk MC, Coward LU, Jackson P, Whitaker JN.

Arch Biochem Biophys. 2000 May 1;377(1):9-21.

PMID:
10775436
28.

Highly related immunoglobulin light chain sequences in different multiple sclerosis patients.

Blalock JE, Zhou SR, Maier CC, Galin FS, Whitaker JN.

J Neuroimmunol. 1999 Dec;100(1-2):98-101.

PMID:
10695719
29.

Neurobiological understanding of myelination in the 21st century.

Whitaker JN.

Arch Neurol. 2000 Jan;57(1):57-8. No abstract available.

PMID:
10634441
30.

Cross-reactive idiotypy in cerebrospinal fluid immunoglobulins in multiple sclerosis.

LaGanke CC, Freeman DW, Whitaker JN.

Ann Neurol. 2000 Jan;47(1):87-92.

PMID:
10632105
32.
33.

Clinical and laboratory features of primary progressive and secondary progressive MS.

Bashir K, Whitaker JN.

Neurology. 1999 Sep 11;53(4):765-71.

PMID:
10489038
34.

Urinary myelin basic protein-like material in patients with multiple sclerosis during interferon beta-1b treatment.

Whitaker JN, Layton BA, Bartolucci AA, Mitchell GW, Bashir K, Goodwin J, Kachelhofer RD.

Arch Neurol. 1999 Jun;56(6):687-91.

PMID:
10369307
35.

Rapid release and unusual stability of immunodominant peptide 45-89 from citrullinated myelin basic protein.

Cao L, Goodin R, Wood D, Moscarello MA, Whitaker JN.

Biochemistry. 1999 May 11;38(19):6157-63.

PMID:
10320343
36.
38.

Age-related changes in the level of urinary myelin basic protein-like material during childhood.

Percy AK, Lane JB, Goodwin J, Kachelhofer RD, Whitaker JN.

Neurology. 1998 Nov;51(5):1339-41.

PMID:
9818857
40.

Reciprocal stimulation between TNF-alpha and nitric oxide may exacerbate CNS inflammation in experimental autoimmune encephalomyelitis.

Sun D, Coleclough C, Cao L, Hu X, Sun S, Whitaker JN.

J Neuroimmunol. 1998 Aug 14;89(1-2):122-30.

PMID:
9726834
41.
42.

Effects of pregnancy and delivery on disease activity in multiple sclerosis.

Whitaker JN.

N Engl J Med. 1998 Jul 30;339(5):339-40. No abstract available.

PMID:
9682048
43.

Cell death mediated by Fas-FasL interaction between glial cells and MBP-reactive T cells.

Sun D, Whitaker JN, Cao L, Han Q, Sun S, Coleclough C, Mountz J, Zhou T.

J Neurosci Res. 1998 May 15;52(4):458-67.

PMID:
9589391
44.

Current immunotherapy in multiple sclerosis.

Bashir K, Whitaker JN.

Immunol Cell Biol. 1998 Feb;76(1):55-64. Review.

PMID:
9553777
45.

Myelin basic protein in cerebrospinal fluid and other body fluids.

Whitaker JN.

Mult Scler. 1998 Feb;4(1):16-21. Review.

PMID:
9532587
46.

The role of regulatory T cells in Lewis rats resistant to EAE.

Sun D, Wilson DB, Cao L, Whitaker JN.

J Neuroimmunol. 1998 Jan;81(1-2):177-83.

PMID:
9521620
47.

A cross-reactive anti-myelin basic protein idiotope in cerebrospinal fluid cells in multiple sclerosis.

Zhou SR, Maier CC, Mitchell GW, LaGanke CC, Blalock JE, Whitaker JN.

Neurology. 1998 Feb;50(2):411-7.

PMID:
9484364
48.

Inhibition of allergic encephalomyelitis in marmosets by vaccination with recombinant vaccinia virus encoding for myelin basic protein.

Genain CP, Gritz L, Joshi N, Panicali D, Davis RL, Whitaker JN, Letvin NL, Hauser SL.

J Neuroimmunol. 1997 Nov;79(2):119-28.

PMID:
9394784

Supplemental Content

Loading ...
Support Center